Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The pandemic had little impact on mental health symptoms.

2.

Prostate cancer, rectal exams, Casgevy approved for thalassemia, and two million cancer cases.

3.

Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma

4.

Research identifies nearly 200 potential breast carcinogens in food packaging materials

5.

Specific suicidal patterns mark the highest risk.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot